Cargando…

Effectiveness of Paliperidone Palmitate in Reducing Acute Psychiatric Service Use for Patients Suffering from Psychosis—A Retrospective Mirror-Image Study

Poor adherence to antipsychotic treatment is a leading cause of relapse for patients suffering from psychotic disorders and the use of long-acting injectable antipsychotics (LAI) may lead to improved clinical outcomes. This was a 1-year mirror-image study examining the clinical outcomes after monthl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chan, Chun Ting, Verma, Swapna, Subramaniam, Mythily, Abdin, Edimansyah, Tay, Jenny
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9961511/ https://www.ncbi.nlm.nih.gov/pubmed/36834095 http://dx.doi.org/10.3390/ijerph20043403

Ejemplares similares

Two-Year Clinical and Functional Outcomes of an Asian Cohort at Ultra-High Risk of Psychosis
por: Chan, Chun Ting, et al.
Publicado: (2019)

Twenty-Four Week, Randomized, Double-Blind, Placebo-Controlled Trial of Metformin for Antipsychotic-Induced Weight Gain in Patients with First-Episode Psychosis: A Pilot Study
por: Tang, Charmaine, et al.
Publicado: (2021)

Quality of Life and Its Associations with Religiosity and Religious Coping among Outpatients with Psychosis in Singapore
por: Roystonn, Kumarasan, et al.
Publicado: (2021)

Religiosity, Religious Coping and Distress Among Outpatients with Psychosis in Singapore
por: Cetty, Laxman, et al.
Publicado: (2022)

Trajectories of positive, negative and general psychopathology symptoms in first episode psychosis and their relationship with functioning over a 2-year follow-up period
por: Abdin, Edimansyah, et al.
Publicado: (2017)

Chronic Pain: Among Tertiary Care Psychiatric Out-Patients in Singapore—Prevalence and Associations with Psychiatric Disorders
por: Satghare, Pratika, et al.
Publicado: (2022)

The Impact of Paliperidone Palmitate on Hospitalization in Patients with Schizophrenia: A Retrospective Mirror-image Study
por: Oh, So-Young, et al.
Publicado: (2019)

Motivations to quit smoking and challenges faced during cessation among individuals with first episode psychosis in Singapore
por: Sagayadevan, Vathsala, et al.
Publicado: (2019)

Prevalence and impact of peer victimisation among youth seeking treatment at a tertiary psychiatric institution in Singapore: a cross-sectional study
por: Subramaniam, Mythily, et al.
Publicado: (2022)

Clarifying pathways to poor psychological health: The mediating role of psychosocial factors in the relationship between general psychopathology and quality of life impairment in patients diagnosed with schizophrenia
por: Liu, Jianlin, et al.
Publicado: (2019)

Accidental Overdose of Paliperidone Palmitate
por: Ojimba, Chiedozie, et al.
Publicado: (2019)

Mapping the Positive and Negative Syndrome Scale scores to EQ-5D-5L and SF-6D utility scores in patients with schizophrenia
por: Abdin, Edimansyah, et al.
Publicado: (2018)

The Relative Associations of Body Image Dissatisfaction among Psychiatric Out-Patients in Singapore
por: Satghare, Pratika, et al.
Publicado: (2019)

Beyond Recovery: Exploring Growth in the Aftermath of Psychosis
por: Lee, Ying Ying, et al.
Publicado: (2020)

Hoarding symptoms among psychiatric outpatients: confirmatory factor analysis and psychometric properties of the Saving Inventory – Revised (SI-R)
por: Lee, Siau Pheng, et al.
Publicado: (2016)

Mental healthcare utilisation by patients before and after receiving paliperidone palmitate treatment: mirror image analyses
por: Kadra-Scalzo, Giouliana, et al.
Publicado: (2022)

M217. EFFICACY OF PALIPERIDONE PALMITATE ON PSYCHIATRIC SYMPTOMS AND ATTITUDES TOWARD MEDICATION IN SCHIZOPHRENIA
Publicado: (2020)

Subjective quality of life among patients with schizophrenia spectrum disorder and patients with major depressive disorder
por: Tan, Xiao Wei, et al.
Publicado: (2019)

Differences of use between paliperidone palmitate 3 month and paliperidone palmitate 1 month in real practice, with psychotic patients
por: Escobedo-Aedo, P., et al.
Publicado: (2022)

Resilience and associative stigma among mental health professionals in a tertiary psychiatric hospital: a cross-sectional study in Singapore
por: Chang, Sherilyn, et al.
Publicado: (2019)

Partial compliance with long-acting paliperidone palmitate and impact on hospitalization: a 6-year mirror-image study
por: Pappa, Sofia, et al.
Publicado: (2020)

Subjective Quality of Life and Its Associations among First Episode Psychosis Patients in Singapore
por: Satghare, Pratika, et al.
Publicado: (2019)

Effects of Paliperidone Palmitate on Coagulation: An Experimental Study
por: Yılmaz, Enver Demirel, et al.
Publicado: (2014)

PM394. The outcome of paliperidone palmitate in schizophrenia
por: Ju, Po-Chung
Publicado: (2016)

Evaluating Singapore’s CHAT Assessment Service by the World Mental Health Organisation (WHO) “Youth-Friendly” Health Services Framework
por: Lee, Yi Ping, et al.
Publicado: (2019)

Physical activity, sedentary behaviour and smoking status among psychiatric patients in Singapore – a cross-sectional study
por: Seet, Vanessa, et al.
Publicado: (2021)

N-Methyl-D-Aspartate(NMDA) Receptor and Voltage-Gated Potassium Channel (VGKC) Antibody-Associated Encephalitides Presenting as First Episode Acute Psychosis
por: Tang, Charmaine, et al.
Publicado: (2019)

Growth in the Aftermath of Psychosis: Characterizing Post-traumatic Growth in Persons With First Episode Psychosis in Singapore
por: Lee, Ying Ying, et al.
Publicado: (2022)

Real-life effectiveness of transitioning from paliperidone palmitate 1-monthly to paliperidone palmitate 3-monthly long-acting injectable formulation
por: Corbeil, Olivier, et al.
Publicado: (2022)

Pharmacoeconomic analysis of paliperidone palmitate for treating schizophrenia in Greece
por: Einarson, Thomas R, et al.
Publicado: (2012)

Paliperidone palmitate-induced enuresis: a case report
por: Cruz, S., et al.
Publicado: (2022)

Validation of the 12‐item World Health Organization Disability Assessment Schedule 2.0 in individuals with schizophrenia, depression, anxiety, and diabetes in Singapore
por: Abdin, Edimansyah, et al.
Publicado: (2023)

The Relationship between Suicidality and Socio-Demographic Variables, Physical Disorders, and Psychiatric Disorders: Results from the Singapore Mental Health Study 2016
por: Ganesh Kudva, Kundadak, et al.
Publicado: (2021)

Effects of Paliperidone Palmitate on Healthcare Utilization and Costs for Patients with Schizophrenia: A Claim-based Mirror-image Study in South Korea
por: Lee, Dasom, et al.
Publicado: (2020)

Case management in early psychosis intervention programme: Perspectives of clients and caregivers
por: Wong, Horng Hien, et al.
Publicado: (2017)

Positive mental health among health professionals working at a psychiatric hospital
por: Picco, Louisa, et al.
Publicado: (2017)

Manic Symptoms during a Switch from Paliperidone ER to Paliperidone Palmitate in a Patient with Schizophrenia
por: Demirci, Kadir, et al.
Publicado: (2015)

Paliperidone palmitate injection for the acute and maintenance treatment of schizophrenia in adults
por: Kim, Shiyun, et al.
Publicado: (2012)

Paliperidone Palmitate-induced Urinary Incontinence: A Case Report
por: Karslıoǧlu, Ersin Hatice, et al.
Publicado: (2016)

Paliperidone Palmitate for Schizoaffective Disorder: A Review of the Clinical Evidence
por: Greenberg, William M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_2uvl18fpu9gsu01bjvsv1fe5vj